Management of Erdafitinib, a pan-FGFR kinase inhibitor, treatment-emergent adverse events
/ Arlene O. Siefker-Radtke
If you are a doctor, nurse, pharmacist or other healthcare professional with the right to prescribe medicine, you can:
Already a member?
Log in